Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1588, 2007-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site
By Tsuya Asuka Kurata Takayasu Tamiya Akihiro Okamoto Isamu Ueda Shinya Sakai Daisuke Sugimoto Naotoshi Matsumoto Koji Goto Isao Yamamoto Nobuyuki Fukuoka Masahiro Nakagawa Kazuhiko
Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. :
Access to resources
Recommend
Cancer of unknown primary site
By Gallagher Chris J Reznek Rodney H
Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. :
Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. :
Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. :
Bevacizumab in addition to cisplatin and irinotecan is active as treatment for gastric cancer
Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. :